Holy Pulmonary Hypertension, Batman: Method of Treatment Not Constrained by Safety and Efficacy

The US Court of Appeals affirmed a ruling that a method of treatment patent is valid and infringed, as safety and efficacy are not patent concerns. However, certain claims of a product-by-process patent were deemed invalid because the product was already in the prior art. United Therapeutics Corporation v. Liquidia Technologies, Inc.

https://www.jdsupra.com/legalnews/holy-pulmonary-hypertension-batman-2388235/

Posta un commento